ModelEdge
TherapeuticsMD
TXMD
Filing type
10-K/A
Filing date
Mar 31, 2026
Updated
Mar 31, 2026 ยท 7:53 PM

Filing

10-K/AAmended Annual Report

Exhibits

EX-23.1CONSENT OF BERKOWITZ POLLACK BRANTEX-23.2CONSENT OF CARR, RIGGS & INGRAM, L.L.C.EX-31.1CERTIFICATION OF CHIEF EXECUTIVE OFFICEREX-31.2CERTIFICATION OF PRINCIPAL FINANCIAL OFFICEREX-32.1SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICEREX-32.2SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICERGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic